HighVista Strategies’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-68,725
| Closed | -$484K | – | 139 |
|
|
2023
Q2 | $484K | Buy |
+68,725
| New | +$484K | 0.22% | 119 |
|
|
2022
Q4 | – | Sell |
-25,837
| Closed | -$326K | – | 107 |
|
|
2022
Q3 | $326K | Buy |
+25,837
| New | +$326K | 0.19% | 92 |
|
|
2021
Q3 | – | Sell |
-15,316
| Closed | -$242K | – | 128 |
|
|
2021
Q2 | $242K | Hold |
15,316
| – | – | 0.17% | 71 |
|
|
2021
Q1 | $156K | Sell |
15,316
-9,484
| -38% | -$96.6K | 0.12% | 83 |
|
|
2020
Q4 | $185K | Hold |
24,800
| – | – | 0.12% | 73 |
|
|
2020
Q3 | $85K | Buy |
+24,800
| New | +$85K | 0.06% | 87 |
|